Transcatheter Mitral Valve Replacement in Failed Mitral Bioprosthesis: Case Report
Case Reports in Cardiology · 2026-01 · 2026 (1)
DOI: 10.1155/cric/2277200 ↗Kurz gefasst
Fallbericht in der Zeitschrift Case Reports in Cardiology, online erschienen am 02.08.2026. Verfasst von Veselin Valkov und 3 weiteren Autor:innen. Beteiligte Einrichtung: First Cardiology Department, UMHAT "St. Marina", Varna, Bulgaria. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Transcatheter valve‐in‐valve mitral valve replacement (ViV TMVR) is an established therapeutic alternative for selected patients with symptomatic degeneration of a surgical mitral bioprosthesis and high or prohibitive surgical risk. We present a 75‐year‐old woman with a failed Pericarbon More 29‐mm mitral bioprosthesis and severe prosthetic mitral stenosis, which was resolved with transseptal transcatheter ViV TMVR. Baseline echocardiography showed mitral valve area 0.45 cm 2 by pressure half‐time, mean transmitral gradient 13 mmHg, preserved left ventricular systolic function, estimated systolic pulmonary artery pressure of 55 mmHg, and severe tricuspid regurgitation. ECG‐gated computed tomography was performed for proper procedural planning. During the procedure, after dilation of the interatrial septum, an abrupt left‐to‐right shunt caused hemodynamic compromise. Rapid rescue balloon dilation of the stenotic mitral bioprosthesis and subsequent implantation of a 26‐mm SAPIEN 3 valve restored forward transmitral flow, reduced the interatrial shunt to a minimum, and avoided septal occluder implantation. Postprocedural echocardiography showed a mean transmitral gradient of 3.5 mmHg, no intraprosthetic or paravalvular regurgitation, no LVOT obstruction, and a minimal, hemodynamically insignificant residual shunt. At 6‐month, 12‐month, and 2‐year follow‐ups, the patient remained asymptomatic with stable prosthetic valve function, although the estimated pulmonary artery pressure remained mildly to moderately elevated and tricuspid regurgitation persisted at a moderate degree. Beyond demonstrating the feasibility of valve‐in‐valve TMVR, this case highlights that septal dilation in severe prosthetic mitral stenosis can precipitate abrupt hemodynamic deterioration by creating a clinically significant left‐to‐right interatrial shunt before relief of the mitral obstruction.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- First Cardiology Department, UMHAT "St. Marina", Varna, Bulgaria.
- Department of Propaedeutic of Internal Diseases, Medical University Prof. Dr. Paraskev Stoyanov, Varna, Bulgaria.
- Department of Cardiology and Rheumatology, Medical University Prof. Dr. Paraskev Stoyanov, Varna, Bulgaria.
- Department of Cardiology, Motol and Homolka University Hospital Homolka Campus, Prague, Czech Republic.
ORCID-Profile: Veselin Valkov, Nikolay Dragnev, Josef Bis, Nikolay Kalvachev
Zitieren
APA
Valkov, V., Dragnev, N., Bis, J., & Kalvachev, N. (2026). Transcatheter Mitral Valve Replacement in Failed Mitral Bioprosthesis: Case Report. Case Reports in Cardiology, 2026(1). https://doi.org/10.1155/cric/2277200
Vancouver
Valkov V, Dragnev N, Bis J, Kalvachev N. Transcatheter Mitral Valve Replacement in Failed Mitral Bioprosthesis: Case Report. Case Reports in Cardiology. 2026;2026(1). doi:10.1155/cric/2277200
BibTeX
@article{Valkov2026,
author = {Valkov, Veselin and Dragnev, Nikolay and Bis, Josef and Kalvachev, Nikolay},
title = {Transcatheter Mitral Valve Replacement in Failed Mitral Bioprosthesis: Case Report},
journal = {Case Reports in Cardiology},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/cric/2277200}
}
EUVIMED